Topic Review
Ghrelin
Ghrelin is an endogenous ligand for the ghrelin receptor, previously known as the growth hormone secretagogue receptor. This hormone is mainly produced by endocrine cells present in the gastric mucosa. The ghrelin-producing cells are also present in other organs of the body, mainly in the digestive system, but in much smaller amount. Ghrelin exhibits a broad spectrum of physiological effects, such as stimulation of growth hormone secretion, gastric secretion, gastrointestinal motility, and food intake, as well as regulation of glucose homeostasis and bone formation, and inhibition of inflammatory processes.
  • 981
  • 21 Oct 2021
Topic Review
5-Hydroxytryptamine Receptors
5-Hydroxytryptamine (5-HT) receptors, also referred to as serotonin receptors, are a monoamine receptor molecule, activated by the neurotransmitter serotonin.
  • 981
  • 30 Dec 2021
Topic Review
Muslim Heritage in Medicine
Many Greco Arabic Muslim scientists have contributed to the medicine field.
  • 980
  • 17 Aug 2022
Topic Review
TIGIT
TIGIT is a transmembrane glycoprotein comprising one immunoglobulin variable (IgV) domain, a type I transmembrane domain, and a cytoplasmic tail with an immunoreceptor tyrosine-based inhibitory motif (ITIM) and immunoglobulin tyrosine tail (ITT)-like motif.
  • 980
  • 08 Apr 2021
Topic Review
TNAP in Central Nervous System
Tissue-nonspecific alkaline phosphatase (TNAP) is an ectoenzyme bound to the plasma membranes of numerous cells via a glycosylphosphatidylinositol (GPI) moiety. TNAP is one of many proteins localized to Brain microvascular endothelial cells (BMECs), and is highly abundant in human and rodent cerebral microvessels [33]. There are four alkaline phosphatase (AP) isoenzymes in humans and they include: TNAP, germ cell alkaline phosphatase (GCAP), intestinal alkaline phosphatase (IAP), and placental alkaline phosphatase (PLAP). Although TNAP is ubiquitous in many tissue, it is most highly expressed in bone, liver, intestine, kidney, and brain, while the three other AP isoenzymes are expressed in the tissues for which they are named. TNAP is also highly expressed in cerebral microvessels.
  • 980
  • 10 Jun 2021
Topic Review
Squamous Cell Carcinoma
More than 90% of all head and neck cancers (HNCs) are head and neck squamous cell carcinomas (HNSCCs) arising from the mucosal surfaces of the upper aerodigestive tract. HNSCCs are the the sixth most prevalent cancer worldwide, and are often associated with either carcinogens, such as alcohol and tobacco use, or oncogenic human papillomavirus (HPV) infection. HNSCCs have been found to be diverse with a high rate of genetic heterogeneity, resulting in hyper-activation of oncogenes (e.g., PIK3CA and HRAS) and loss-of-function mutations in tumor suppressor genes (e.g., TP53, CASP8, and NOTCH1). HNSCC cohorts from The Cancer Genome Atlas (TCGA) RNA-seq data and clinical data show patients with PIK3CA alterations, including amplification and gain, also have a higher chance of harboring TP53 mutations. In addition, these patients bearing both mutations have a significantly worse 10-year survival prognosis compared with their wildtype cohort counterparts.
  • 980
  • 22 Sep 2020
Topic Review
Exercise Prescriptions for Parkinson’s Disease
Parkinson’s disease (PD) is a prevalent neurodegenerative disorder, which relates to not only motor symptoms, but also cognitive, autonomic, and mood impairments. The literature suggests that pharmacological or surgical treatment has a limited effect on providing relief of the symptoms and also restricting its progression. Recently, research on non-pharmacological interventions for people living with PD (pwPD) that alleviate their motor and non-motor features has shown a new aspect in treating this complex disease. Numerous studies are supporting exercise intervention as being effective in both motor and non-motor facets of PD, such as physical functioning, strength, balance, gait speed, and cognitive impairment. Via the lens of the physical profession, this paper strives to provide another perspective for PD treatment by presenting exercise modes categorized by motor and non-motor PD symptoms, along with its effects and mechanisms. Acknowledging that there is no “one size fits all” exercise prescription for such a variable and progressive disease, this review is to outline tailored physical activities as a credible approach in treating pwPD, conceivably enhancing overall physical capacity, ameliorating the symptoms, reducing the risk of falls and injuries, and, eventually, elevating the quality of life. It also provides references and practical prescription applications for the clinician.
  • 980
  • 30 Oct 2020
Topic Review
Chemotherapy Resistance
Multidrug resistance is a major factor contributing to the failure of cancer therapy and poor patient outcomes. While apoptosis (apoptotic cell death) is the desired outcome of anti-cancer therapy, chemotherapy and radiation often induce a number of mechanisms that can mediate resistance. p53 is an essential tumor suppressor and stress response protein, modulating multiple cellular responses to therapy. Gain of function (GOF) p53 mutations have been implicated in increased susceptibility to the development of drug resistance, by compromising wild type anti-tumor functions of p53 or modulating key p53 processes that confer chemotherapy resistance, such as autophagy. Autophagy, a conventionally cytoprotective mechanism, is often a “first responder” to chemotherapy (or radiation), by promoting the removal of damaged organelles and preventing excessive accumulation of damaged proteins; thus, autophagy, via its cytoprotectivefunction, may allow tumor cells to evade apoptotic cell death. However, substantial pre-clinical data and inconsistent clinical efficacy of autophagy inhibitors in combination with cancer chemotherapy indicates that autophagy can exhibit multiple functions and does not act solely as a cytoprotective response. Further inquiry relating to the influence of p53 status on autophagic function and its contributions to multidrug resistance will provide valuable insights towards patient response to therapy and the possibility of developing novel therapeutics for chemosensitization in the face of multidrug resistance. 
  • 980
  • 16 Dec 2020
Topic Review
Bacterial Virulence Factors
There are several levels to influence the expression of eukaryotic genes. A first level of interference is changing of the DNA’s structure on the chromatin level. Epigenetic modulation enables remodelling of the chromatin to transfer heterochromatin into euchromatin allowing transcription or vice versa. In addition, the affinity of promotors and other regulatory DNA sequences for RNA polymerases and transcription factors (TFs) can be influenced by cytosine or adenine methylation. Only a minor portion (fewer than 2%) of genes is transcribed into mRNAs, instead the majority is transferred into so called non-coding RNAs (ncRNAs). Certain long ncRNAs (lncRNAs) are also involved in epigenetic regulations. Epigenetic mechanisms are used for manipulation of gene expression in the course of several cellular processes. Here, we give an overview on the epigenetic control of gene expression by bacterial virulence factors during host cell infection.
  • 979
  • 27 Oct 2020
Topic Review
Bispecific Antibody-Based Immune-Cell Engagers in Cancer Immunotherapy
Cancer is the second leading cause of death worldwide after cardiovascular diseases. One of the most promising targeted therapies for cancer treatment is antibody therapy. It has a superior targeting ability for antigens that are expressed on cancer cells, which results in prominent antitumor activity and lower toxicity, compared with that of chemotherapeutic agents. Recent progress in recombinant DNA technology and antibody engineering has ushered in a new era of bispecific antibody (bsAb)-based immune-cell engagers (ICEs), including T- and natural-killer-cell engagers.
  • 978
  • 06 Jan 2023
  • Page
  • of
  • 1352
ScholarVision Creations